Physician profile
Rakhee Patel
NPI 1124316336
$7,979.79
in general payments reported to CMS, 2019-2025
31 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,205 · 2020: $122 · 2021: $1,388 · 2022: $128 · 2023: $355 · 2024: $401 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,038 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,037.69 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,112.23 | 2019-2020 | |
| Ethicon INC. | $1,205.00 | 2021 | |
| Exeltis, USA INC. | $357.95 | 2023-2025 | Slynd |
| Astellas Pharma US INC | $238.24 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $187.81 | 2021-2025 | Novasure, Acessa Provu System, Myosure Tissue Removal Device |
| Evofem Biosciences, INC. | $148.20 | 2021-2025 | Phexxi, Solosec, Phexx |
| Abbvie INC. | $67.52 | 2019-2023 | |
| Medtronic, INC. | $65.91 | 2023 | Truclear |
| Mayne Pharma Commercial LLC | $50.51 | 2022-2023 | |
| Covidien LP | $45.71 | 2019 | |
| Mimedx Group, INC. | $43.90 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.11 | 2020-2023 | |
| Lupin INC. | $37.12 | 2019-2020 | |
| Shield Therapeutics INC | $34.85 | 2024-2025 | |
| Organon LLC | $30.76 | 2021-2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $29.88 | 2022-2023 | Balcoltra |
| Pfizer INC. | $28.14 | 2021-2022 | |
| Therapeuticsmd, INC. | $25.40 | 2020-2021 | |
| Meditrina | $24.27 | 2023 | |
| Medicem INC. | $24.16 | 2020 | |
| Convatec INC. | $24.07 | 2023 | |
| Exact Sciences Corporation | $20.05 | 2025 | The Cologuard Plus Collection Kit |
| Avanos Medical | $18.74 | 2019 | |
| Myovant Sciences INC. | $16.67 | 2022 | |
| Mannkind Corporation | $15.91 | 2024 | |
| Mission Pharmacal Company | $15.48 | 2023 | Citranatal |
| Gilead Sciences, INC. | $15.17 | 2025 | |
| Vertical Pharmaceuticals, LLC | $15.00 | 2019 | |
| Millicent US INC | $14.37 | 2019 | |
| Scynexis, INC. | $13.56 | 2022 | |
| Boston Scientific Corporation | $11.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rakhee Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.